ORDONEZ KATHY 4
4 · PACIFIC BIOSCIENCES OF CALIFORNIA, INC. · Filed Jun 4, 2026
Research Summary
AI-generated summary of this filing
PacBio (PACB) Director Kathy Ordonez Receives 223,492-Share Award
What Happened Kathy Ordonez, a director of Pacific Biosciences of California, Inc. (PACB), received a derivative award on 2026-06-03 for 223,492 shares (reported as an acquisition at $0.00). The Form 4 classifies this as a grant/award (transaction code A); the filing reports $0 aggregate value because the award is a derivative (option-like) grant rather than an open-market purchase.
Key Details
- Transaction date: 2026-06-03; Form 4 filed 2026-06-04 (timely).
- Shares granted: 223,492 (derivative award) at $0.00 per share; aggregate reported value $0.
- Vesting: The award vests monthly over one year (see footnote F1). Vesting may accelerate to the next annual meeting if earlier, provided she remains a director.
- Shares owned after the transaction: not specified in the provided excerpt of the filing.
- Transaction type/code: A = Grant/Award (derivative securities).
Context This was a compensation grant of derivative securities (an option-like award) rather than an open-market purchase or sale. The shares are subject to a vesting schedule and were not immediately sold; such grants are common for board compensation and align long-term incentives with shareholders but do not by themselves indicate the insider’s view of near-term stock performance.
Insider Transaction Report
- Award
Stock Option (right to buy)
[F1]2026-06-03+223,492→ 223,492 totalExercise: $1.58From: 2026-07-03Exp: 2036-06-03→ Common Stock (223,492 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest monthly over one (1) year, on the same day of the month as the date of grant or, if earlier, on the date of the next annual meeting of the Company's stockholders occurring after the date of grant, provided such Reporting Person continues to serve as a director through the applicable vesting dates.